Varying Chirality Across Nicotinic Acetylcholine Receptor Subtypes: Selective Binding of Quinuclidine Triazole Compounds

作者: Jiradanai Sarasamkan , Matthias Scheunemann , Nattayaporn Apaijai , Siripong Palee , Warisara Parichatikanond

DOI: 10.1021/ACSMEDCHEMLETT.6B00146

关键词:

摘要: The novel quinuclidine anti-1,2,3-triazole derivatives T1–T6 were designed based on the structure of QND8. binding studies revealed that stereochemistry at C3 position scaffold plays an important role in nAChR subtype selectivity. Whereas (R)-enantiomers are selective to α7 over α4β2 (by factors 44–225) and a smaller degree α3β4 (3–33), their (S)-counterparts prefer (62–237) as well (5–294). (R)-derivatives highly subtypes compared (RS)- (R)-QND8. (S)-enantiomers 5–10 times more than (R) forms. overall strongest affinity is observed for (S)-enantiomer (Ki, 2.25–19.5 nM) followed by (R)-counterpart 22.5–117 nM), with significantly weaker 414–1980 still above very weak respective (R)-analogue 5059–10436 nM).

参考文章(33)
Peter Brust, Winnie Deuther-Conrad, Cornelius K Donat, Henryk Barthel, Patrick Riss, Louise Paterson, Alexander Höpping, Osama Sabri, Paul Cumming, None, Preclinical Aspects of Nicotinic Acetylcholine Receptor Imaging PET and SPECT of Neurobiological Systems. pp. 465- 512 ,(2014) , 10.1007/978-3-642-42014-6_17
Susmita Chatterjee, Pia Steensland, Jeffrey A Simms, Joan Holgate, Jotham W Coe, Raymond S Hurst, Christopher L Shaffer, John Lowe, Hans Rollema, Selena E Bartlett, Partial agonists of the α3β4* neuronal nicotinic acetylcholine receptor reduce ethanol consumption and seeking in rats. Neuropsychopharmacology. ,vol. 36, pp. 603- 615 ,(2011) , 10.1038/NPP.2010.191
Massimiliano Beltramo, Vincent Robert, Mathieu Galibert, Jean-Baptiste Madinier, Philippe Marceau, Hugues Dardente, Caroline Decourt, Nicolas De Roux, Didier Lomet, Agnès F. Delmas, Alain Caraty, Vincent Aucagne, Rational design of triazololipopeptides analogs of kisspeptin inducing a long-lasting increase of gonadotropins. Journal of Medicinal Chemistry. ,vol. 58, pp. 3459- 3470 ,(2015) , 10.1021/JM5019675
Donn G. Wishka, Daniel P. Walker, Karen M. Yates, Steven C. Reitz, Shaojuan Jia, Jason K. Myers, Kirk L. Olson, E. Jon Jacobsen, Mark L. Wolfe, Vincent E. Groppi, Alexander J. Hanchar, Bruce A. Thornburgh, Luz A. Cortes-Burgos, Erik H. F. Wong, Brian A. Staton, Thomas J. Raub, Nicole R. Higdon, Theron M. Wall, Raymond S. Hurst, Rodney R. Walters, William E. Hoffmann, Mihaly Hajos, Stanley Franklin, Galen Carey, Lisa H. Gold, Karen K. Cook, Steven B. Sands, Sabrina X. Zhao, John R. Soglia, Amit S. Kalgutkar, Stephen P. Arneric, Bruce N. Rogers, Discovery of N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an Agonist of the α7 Nicotinic Acetylcholine Receptor, for the Potential Treatment of Cognitive Deficits in Schizophrenia: Synthesis and Structure−Activity Relationship Journal of Medicinal Chemistry. ,vol. 49, pp. 4425- 4436 ,(2006) , 10.1021/JM0602413
Shafiqur Rahman, Eric A. Engleman, Richard L. Bell, Nicotinic receptor modulation to treat alcohol and drug dependence Frontiers in Neuroscience. ,vol. 8, pp. 426- 426 ,(2015) , 10.3389/FNINS.2014.00426
Kelly T. Dineley, Anshul A. Pandya, Jerrel L. Yakel, Nicotinic ACh receptors as therapeutic targets in CNS disorders Trends in Pharmacological Sciences. ,vol. 36, pp. 96- 108 ,(2015) , 10.1016/J.TIPS.2014.12.002
Arup K. Ghose, Torsten Herbertz, Robert L. Hudkins, Bruce D. Dorsey, John P. Mallamo, Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery ACS Chemical Neuroscience. ,vol. 3, pp. 50- 68 ,(2012) , 10.1021/CN200100H
Cecilia Gotti, Francesco Clementi, Alice Fornari, Annalisa Gaimarri, Stefania Guiducci, Irene Manfredi, Milena Moretti, Patrizia Pedrazzi, Luca Pucci, Michele Zoli, Structural and functional diversity of native brain neuronal nicotinic receptors Biochemical Pharmacology. ,vol. 78, pp. 703- 711 ,(2009) , 10.1016/J.BCP.2009.05.024